Health Results-Based Financing Impact Evaluation 2013, Health Facility Baseline Survey
Burkina Faso, 2013 - 2014
Get Microdata
Reference ID
BFA_2013_HRBFIE-FBL_v01_M
Producer(s)
Paul Jacob Robyn, Aurelia Souares, Herve Hien
Collection(s)
Metadata
Created on
Jan 13, 2017
Last modified
Jan 17, 2017
Page views
123979
Downloads
9748
F6_221_Médicament acheté 6 (f6_221_6)
Data file: f6_aug19
Overview
Valid:
38
Invalid:
0
Type:
Discrete
Start:
1053
End:
1077
Width:
25
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ACT | 1 |
2.6%
|
|
| ALBENDAZOLE SUSPENSION | 1 |
2.6%
|
|
| AMPICILLINE | 2 |
5.3%
|
|
| AMPICILLINE 500 | 1 |
2.6%
|
|
| ASL | 1 |
2.6%
|
|
| ASL 900 | 1 |
2.6%
|
|
| AST | 1 |
2.6%
|
|
| BANDE | 1 |
2.6%
|
|
| CARBOTOUX | 1 |
2.6%
|
|
| CHLORPHENIRAMINE | 3 |
7.9%
|
|
| COTRIMOXAZOL | 1 |
2.6%
|
|
| EPPI | 1 |
2.6%
|
|
| FAF FER ACIDE FOLIQUE | 1 |
2.6%
|
|
| GANTS | 2 |
5.3%
|
|
| GANTS STERIL | 1 |
2.6%
|
|
| GANTS VRAC | 1 |
2.6%
|
|
| MEBENDAZOLE | 2 |
5.3%
|
|
| MEBENDAZOLE* | 1 |
2.6%
|
|
| METO | 1 |
2.6%
|
|
| METO INJECTABLE | 1 |
2.6%
|
|
| METOCLOPRAMIDE | 1 |
2.6%
|
|
| METOCLOPRAMIDE INJECTABLE | 1 |
2.6%
|
|
| MODECATE | 1 |
2.6%
|
|
| NOVALGIN | 1 |
2.6%
|
|
| NYSTATINE | 1 |
2.6%
|
|
| PARACETAMOL COMP | 1 |
2.6%
|
|
| QUININE | 1 |
2.6%
|
|
| SERINGUE | 2 |
5.3%
|
|
| SERINGUE 5CC | 1 |
2.6%
|
|
| SRO | 1 |
2.6%
|
|
| SRO ZINC | 1 |
2.6%
|
|
| SULFATE DE ZINC | 1 |
2.6%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.